EGFR and glioblastoma: Aberrant activation of the epidermal growth factor receptor (EGFR), a tyrosine kinase receptor that binds ligands of the epidermal growth factor family, plays an important role in GBM, where dysregulated expression or activity is associated with tumor development, progression, metastatic spread, and decreased survival [9–11].